Pluri Inc. Investment Income, Interest
Pluri Inc. (PLUR) reported Investment Income, Interest of $488.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-09-10
- Pluri Inc. investment income, interest for the quarter ending 2026-06-30 was $73.00K, a 76.60% decline year-over-year.
- Pluri Inc. investment income, interest for the quarter ending 2026-03-31 was $104.00K, a 60.00% decline year-over-year.
- Pluri Inc. investment income, interest for the quarter ending 2025-12-31 was $118.00K, a 52.99% decline year-over-year.
- Pluri Inc. investment income, interest for the quarter ending 2025-09-30 was $193.00K, a 39.88% decline year-over-year.
- Pluri Inc. investment income, interest for fiscal 2026 was $488.00K, a 57.34% decline from fiscal 2025.
- Pluri Inc. investment income, interest for fiscal 2025 was $1.14M, a 18.63% decline from fiscal 2024.
- Pluri Inc. investment income, interest for fiscal 2024 was $1.41M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $177.00K derived: sum of 2 quarters · filed 2026-09-10 | $295.00K derived: sum of 3 quarters · filed 2026-09-10 | $488.00K 10-K · filed 2026-09-10 |
| 2026-03-31 | $104.00K 10-Q · filed 2026-05-14 | $222.00K derived: sum of 2 quarters · filed 2026-05-14 | $415.00K 10-Q · filed 2026-05-14 | $727.00K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-12-31 | $118.00K 10-Q · filed 2026-02-12 | $311.00K 10-Q · filed 2026-02-12 | $623.00K derived: sum of 3 quarters · filed 2026-09-10 | $883.00K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-09-30 | $193.00K 10-Q · filed 2025-11-12 | $505.00K derived: sum of 2 quarters · filed 2026-09-10 | $765.00K derived: sum of 3 quarters · filed 2026-09-10 | $1.02M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-06-30 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $572.00K derived: sum of 2 quarters · filed 2026-09-10 | $823.00K derived: sum of 3 quarters · filed 2026-09-10 | $1.14M 10-K · filed 2026-09-10 |
| 2025-03-31 | $260.00K 10-Q · filed 2026-05-14 | $511.00K derived: sum of 2 quarters · filed 2026-05-14 | $832.00K 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $251.00K 10-Q · filed 2026-02-12 | $572.00K 10-Q · filed 2026-02-12 | ||
| 2024-09-30 | $321.00K 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | $1.41M 10-K · filed 2025-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |